CJC-1295 DAC

CJC-1295 (DAC) is a synthetic growth hormone-releasing hormone (GHRH) analogue modified with Drug Affinity Complex (DAC) technology, allowing extended biological activity in research settings. It is widely studied in laboratory environments focused on endocrine signaling, growth hormone regulation, and metabolic pathway analysis.

This research-grade formulation is supplied under strict manufacturing conditions to ensure high purity, stability, and consistency for scientific investigation. It is intended strictly for laboratory and analytical use only.

Features

• CJC-1295 DAC research compound
• Long-acting GHRH analogue peptide
• High-purity laboratory-grade material
• Studied in endocrine and metabolic research
• Extended activity via DAC modification
• Stable and securely sealed vial
• Intended for research purposes only

Applications

• Growth hormone pathway research
• Endocrine signaling studies
• Metabolic regulation investigations
• Cellular and biochemical analysis
• Laboratory-based experimental research
• Academic and scientific studies